NO950889L - Nanopartikler inneholdende et virksomt stoff og et polyketalvinsyreamid, fremgangsmåter for fremstilling derav og anvendelse av partiklene - Google Patents

Nanopartikler inneholdende et virksomt stoff og et polyketalvinsyreamid, fremgangsmåter for fremstilling derav og anvendelse av partiklene

Info

Publication number
NO950889L
NO950889L NO950889A NO950889A NO950889L NO 950889 L NO950889 L NO 950889L NO 950889 A NO950889 A NO 950889A NO 950889 A NO950889 A NO 950889A NO 950889 L NO950889 L NO 950889L
Authority
NO
Norway
Prior art keywords
polyketal
particles
processes
preparation
active substance
Prior art date
Application number
NO950889A
Other languages
English (en)
Other versions
NO307422B1 (no
NO950889D0 (no
Inventor
Michael Ahlers
Axel Walch
Gerhard Seipke
Gregory John Russell-Jones
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO950889D0 publication Critical patent/NO950889D0/no
Publication of NO950889L publication Critical patent/NO950889L/no
Publication of NO307422B1 publication Critical patent/NO307422B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
    • A61K47/6931—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer
    • A61K47/6933—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer the polymer being obtained by reactions only involving carbon to carbon, e.g. poly(meth)acrylate, polystyrene, polyvinylpyrrolidone or polyvinylalcohol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/84—Manufacture, treatment, or detection of nanostructure
    • Y10S977/90—Manufacture, treatment, or detection of nanostructure having step or means utilizing mechanical or thermal property, e.g. pressure, heat
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO950889A 1994-03-09 1995-03-08 Nanopartikler inneholdende et virksomt stoff og et polyketalvinsyreamid, fremgangsmåter for fremstilling derav og anvendelse av partiklene NO307422B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4407898A DE4407898A1 (de) 1994-03-09 1994-03-09 Nanopartikel, enthaltend einen Wirkstoff und ein Polyketalweinsäureamid, Verfahren zu ihrer Herstellung und Verwendung derselben

Publications (3)

Publication Number Publication Date
NO950889D0 NO950889D0 (no) 1995-03-08
NO950889L true NO950889L (no) 1995-09-11
NO307422B1 NO307422B1 (no) 2000-04-03

Family

ID=6512297

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950889A NO307422B1 (no) 1994-03-09 1995-03-08 Nanopartikler inneholdende et virksomt stoff og et polyketalvinsyreamid, fremgangsmåter for fremstilling derav og anvendelse av partiklene

Country Status (14)

Country Link
US (1) US5674531A (no)
EP (1) EP0671169A1 (no)
JP (1) JPH07258114A (no)
KR (1) KR950031051A (no)
AU (1) AU685577B2 (no)
CA (1) CA2144216A1 (no)
DE (1) DE4407898A1 (no)
FI (1) FI951053A (no)
HU (1) HUT72033A (no)
IL (1) IL112905A (no)
NO (1) NO307422B1 (no)
NZ (1) NZ270648A (no)
TW (1) TW457096B (no)
ZA (1) ZA951910B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
AUPO888097A0 (en) * 1997-08-29 1997-09-25 Biotech Australia Pty Limited Cross-linked particles
DE19745950A1 (de) * 1997-10-17 1999-04-22 Dds Drug Delivery Service Ges Arzneistoffträgerpartikel für die gewebespezifische Arzneistoffapplikation
DE19810965A1 (de) * 1998-03-13 1999-09-16 Aventis Res & Tech Gmbh & Co Nanopartikel, Verfahren zu ihrer Herstellung und ihre Verwendung
US20040126900A1 (en) * 2001-04-13 2004-07-01 Barry Stephen E High affinity peptide- containing nanoparticles
US20060280761A1 (en) * 2002-03-11 2006-12-14 Health Plus International, Inc. Nanofluidized B-12 composition and process for treating pernicious anemia
TW200404820A (en) * 2002-06-14 2004-04-01 Rohm & Haas Aqueous nanoparticle dispersions
JP4975966B2 (ja) * 2002-12-31 2012-07-11 ネクター セラピューティクス ケトンまたは関連する官能基を含むポリマー試薬
CA2482240A1 (en) * 2004-09-27 2006-03-27 Claude Choquet Body motion training and qualification system and method
CN101438252A (zh) * 2004-10-07 2009-05-20 爱莫里大学 多功能纳米粒子共轭体及其应用
FR2904219B1 (fr) * 2006-07-28 2010-08-13 Flamel Tech Sa Microparticules a base de copolymere amphiphile et de principe(s) actif(s) a liberation modifiee et formulations pharmaceutiques en contenant
GB0814953D0 (en) * 2008-08-18 2008-09-24 Unilever Plc Improvements relating to nanodisperse compositions
JP5691273B2 (ja) * 2009-07-23 2015-04-01 Jnc株式会社 液晶配向剤、液晶配向膜及び液晶表示素子
US11344859B2 (en) 2019-11-27 2022-05-31 Smartdyelivery Gmbh Reactor for the preparation of a formulation
DE102019218404A1 (de) * 2019-11-27 2021-05-27 Smartdyelivery Gmbh Reaktor zur Herstellung einer Formulierung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297033A (en) * 1963-10-31 1967-01-10 American Cyanamid Co Surgical sutures
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
DE69221568T2 (de) * 1991-04-02 1998-03-19 Biotech Australia Pty. Ltd., Roseville, New South Wales Systeme zur oralen freisetzung von mikropartikeln
EP0514790A2 (de) * 1991-05-24 1992-11-25 Hoechst Aktiengesellschaft Polykondensate, die Weinsäurederivate enthalten, Verfahren zu ihrer Herstellung und Verwendung derselben

Also Published As

Publication number Publication date
EP0671169A1 (de) 1995-09-13
ZA951910B (en) 1995-11-13
HU9500698D0 (en) 1995-04-28
IL112905A0 (en) 1995-06-29
JPH07258114A (ja) 1995-10-09
IL112905A (en) 2000-08-31
AU685577B2 (en) 1998-01-22
CA2144216A1 (en) 1995-09-10
NO307422B1 (no) 2000-04-03
NO950889D0 (no) 1995-03-08
DE4407898A1 (de) 1995-09-14
TW457096B (en) 2001-10-01
HUT72033A (en) 1996-03-28
FI951053A (fi) 1995-09-10
NZ270648A (en) 1995-09-26
FI951053A0 (fi) 1995-03-07
AU1470195A (en) 1995-09-21
KR950031051A (ko) 1995-12-18
US5674531A (en) 1997-10-07

Similar Documents

Publication Publication Date Title
NO950889D0 (no) Nanopartikler inneholdende et virksomt stoff og et polyketalvinsyreamid, fremgangsmåter for fremstilling derav og anvendelse av partiklene
HU903876D0 (en) Pesticide preparatives containing n-phenyl-pyrazole derivatives and process for producing the active substance
DE69602156D1 (de) Elektroden und deren Herstellungsverfahren
HUT49877A (en) Herbicides comprising heterocyclic alkylenequinoxalinyl oxyphenoxypropionate and process for producing the active ingredients
DE69617806D1 (de) Aktives Antischwingungsgerät und dessen Herstellungsweise
HU902253D0 (en) Insecticide preparatives containing phenyl-substituted heterocyclic compounds as active substance and process for producing the active substances
CS970186A2 (en) Insecticide and acaricide and method of active substances production
KR950701924A (ko) 신규한 생물학적으로 활성인 에부르나메닌 유도체 및 그 유도체가 함유된 약제학적 조성물과 그 제조방법
FI963385A0 (fi) Poresysteemin ja aktiivisen farmaseuttisen aineen sisältävä rakeinen tuote tai tabletti sekä menetelmä sen valmistamiseksi
HU906362D0 (en) Herbicide preparatives containing carboxylic acid amides and process for producing the active substances
BR9607750A (pt) Compostos de ácido pirrolidinil-hidroxâmico e seus processos de produção
EE9600023A (et) Fenüültsükloheksüülkarboksüülhappeamiidid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud ühendeid sisaldavad ravimid ja nende valmistamismeetod
PL240271A1 (en) Agent against ectroparasites and method of preparation of novel derivatives of 2-/phenoxyalkyl/-imidazole constituting the active substance of the agent
PL238644A1 (en) Herbicide and method of manufacture of its active substance
CS919584A2 (en) Herbicide and method of its active substance
FI98861B (fi) Menetelmä mikrohuokoisen, kaasua läpäisevän elektrodin valmistamiseksisekä mikrohuokoinen kaasua läpäisevä elektrodi
HU911832D0 (en) Herbicide preparatives containing new aryl-oxi-alkyl-indoline derivatives as active substance and process for producing said active substances
PT76805A (de) N-(2-methoxyethyl)-noroxymorphon dessen saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
HUP9802332A3 (en) Fungicidal carbamoyl carboxylic acid amide derivatives, preparation and use thereof
HUT50507A (en) Insecticides and process for production of the active substance
DE59502325D1 (de) Arzneimittelszusammensetzung aus S-Milchsäure und dessen Verwendung
NO930946D0 (no) Doseringsaerosoler som inneholder virkestoffet flezelastin og forbindelser av beslektet natur
HUT43246A (en) Herbicides containing as active substance derivatives of 1-aryl-5-hydrazin-pirasole and process for production of the active substance
CS107084A2 (en) Insecticide and method of its active substance production
HUT46993A (en) Herbicides containing active substance of derivatives of sulphonil-carbamide and antidotum of glycin-amid derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2002